annual FCF:
$220.04M+$106.06M(+93.06%)Summary
- As of today (August 16, 2025), AMRX annual free cash flow is $220.04 million, with the most recent change of +$106.06 million (+93.06%) on December 31, 2024.
- During the last 3 years, AMRX annual FCF has risen by +$27.65 million (+14.37%).
- AMRX annual FCF is now -30.85% below its all-time high of $318.21 million, reached on December 31, 2020.
Performance
AMRX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$56.42M+$67.33M(+616.92%)Summary
- As of today (August 16, 2025), AMRX quarterly free cash flow is $56.42 million, with the most recent change of +$67.33 million (+616.92%) on June 30, 2025.
- Over the past year, AMRX quarterly FCF has increased by +$28.21 million (+100.04%).
- AMRX quarterly FCF is now -76.46% below its all-time high of $239.63 million, reached on December 31, 2018.
Performance
AMRX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$261.58M+$28.21M(+12.09%)Summary
- As of today (August 16, 2025), AMRX TTM free cash flow is $261.58 million, with the most recent change of +$28.21 million (+12.09%) on June 30, 2025.
- Over the past year, AMRX TTM FCF has increased by +$85.50 million (+48.56%).
- AMRX TTM FCF is now -35.83% below its all-time high of $407.64 million, reached on March 31, 2021.
Performance
AMRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AMRX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +93.1% | +100.0% | +48.6% |
| 3 y3 years | +14.4% | +139.6% | +227.9% |
| 5 y5 years | +329.9% | -67.0% | -7.4% |
AMRX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +910.2% | -55.9% | +139.6% | -5.4% | +1126.0% |
| 5 y | 5-year | -30.9% | +329.9% | -67.0% | +139.6% | -35.8% | +1126.0% |
| alltime | all time | -30.9% | +329.9% | -76.5% | +139.6% | -35.8% | +335.3% |
AMRX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $56.42M(-616.9%) | $261.58M(+12.1%) |
| Mar 2025 | - | -$10.91M(-111.5%) | $233.37M(+6.0%) |
| Dec 2024 | $220.04M(+93.1%) | $95.01M(-21.5%) | $220.11M(-4.0%) |
| Sep 2024 | - | $121.06M(+329.3%) | $229.23M(+30.2%) |
| Jun 2024 | - | $28.20M(-216.7%) | $176.07M(+41.7%) |
| Mar 2024 | - | -$24.17M(-123.2%) | $124.24M(-55.0%) |
| Dec 2023 | $113.97M(-519.7%) | $104.13M(+53.3%) | $276.39M(+101.0%) |
| Sep 2023 | - | $67.91M(-387.4%) | $137.50M(+20.8%) |
| Jun 2023 | - | -$23.63M(-118.5%) | $113.83M(-2296.6%) |
| Mar 2023 | - | $127.97M(-468.2%) | -$5.18M(-79.7%) |
| Dec 2022 | -$27.16M(-114.1%) | -$34.76M(-178.6%) | -$25.50M(-147.9%) |
| Sep 2022 | - | $44.24M(-131.0%) | $53.27M(-33.2%) |
| Jun 2022 | - | -$142.64M(-232.5%) | $79.76M(-50.6%) |
| Mar 2022 | - | $107.66M(+144.6%) | $161.41M(-14.7%) |
| Dec 2021 | $192.39M(-39.5%) | $44.01M(-37.8%) | $189.18M(-13.7%) |
| Sep 2021 | - | $70.73M(-216.0%) | $219.34M(+24.7%) |
| Jun 2021 | - | -$60.99M(-145.0%) | $175.96M(-56.8%) |
| Mar 2021 | - | $135.44M(+82.6%) | $407.64M(+30.3%) |
| Dec 2020 | $318.21M(-432.4%) | $74.16M(+171.1%) | $312.81M(+70.9%) |
| Sep 2020 | - | $27.35M(-84.0%) | $183.00M(-35.2%) |
| Jun 2020 | - | $170.69M(+320.3%) | $282.52M(+296.3%) |
| Mar 2020 | - | $40.61M(-173.0%) | $71.28M(-174.5%) |
| Dec 2019 | -$95.73M | -$55.66M(-143.9%) | -$95.73M(-148.0%) |
| Sep 2019 | - | $126.88M(-412.9%) | $199.56M(+105.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$40.55M(-67.9%) | $97.35M(+406.6%) |
| Mar 2019 | - | -$126.40M(-152.7%) | $19.21M(-87.5%) |
| Dec 2018 | $153.14M(+27.7%) | $239.63M(+871.6%) | $153.14M(-277.1%) |
| Sep 2018 | - | $24.66M(-120.8%) | -$86.49M(-22.2%) |
| Jun 2018 | - | -$118.68M(-1676.1%) | -$111.15M(-1576.1%) |
| Mar 2018 | - | $7.53M | $7.53M |
| Dec 2017 | $119.92M(+452.7%) | - | - |
| Dec 2016 | $21.70M(-46.9%) | - | - |
| Dec 2015 | $40.88M(-504.9%) | - | - |
| Dec 2014 | -$10.10M(-109.6%) | - | - |
| Dec 2013 | $105.16M(-260.7%) | - | - |
| Dec 2012 | -$65.45M(+170.8%) | - | - |
| Dec 2011 | -$24.17M(-110.3%) | - | - |
| Dec 2010 | $233.49M(-1134.3%) | - | - |
| Dec 2009 | -$22.57M(-158.3%) | - | - |
| Dec 2008 | $38.70M(-61.4%) | - | - |
| Dec 2007 | $100.18M(-467.8%) | - | - |
| Dec 2006 | -$27.23M(-526.3%) | - | - |
| Dec 2005 | $6.39M(-127.0%) | - | - |
| Dec 2003 | -$23.63M(-21.9%) | - | - |
| Dec 2002 | -$30.25M(-12.2%) | - | - |
| Dec 2001 | -$34.45M(+76.1%) | - | - |
| Dec 2000 | -$19.57M(+172.0%) | - | - |
| Dec 1999 | -$7.19M(+44.7%) | - | - |
| Dec 1998 | -$4.97M | - | - |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual free cash flow?
- What is the all time high annual FCF for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual FCF year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly FCF year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM FCF year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual free cash flow?
The current annual FCF of AMRX is $220.04M
What is the all time high annual FCF for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual free cash flow is $318.21M
What is Amneal Pharmaceuticals, Inc. annual FCF year-on-year change?
Over the past year, AMRX annual free cash flow has changed by +$106.06M (+93.06%)
What is Amneal Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly FCF of AMRX is $56.42M
What is the all time high quarterly FCF for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly free cash flow is $239.63M
What is Amneal Pharmaceuticals, Inc. quarterly FCF year-on-year change?
Over the past year, AMRX quarterly free cash flow has changed by +$28.21M (+100.04%)
What is Amneal Pharmaceuticals, Inc. TTM free cash flow?
The current TTM FCF of AMRX is $261.58M
What is the all time high TTM FCF for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM free cash flow is $407.64M
What is Amneal Pharmaceuticals, Inc. TTM FCF year-on-year change?
Over the past year, AMRX TTM free cash flow has changed by +$85.50M (+48.56%)